Product
Placebo-Apremilast
1 clinical trial
1 indication
Indication
ParapsoriasisClinical trial
A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque PsoriasisStatus: Completed, Estimated PCD: 2016-02-12